The 2025 lung cancer landscape: advances in screening, molecular taxonomy and therapeutic strategy: a narrative review
{{output}}
Background and objective: In 2025, lung cancer research advanced rapidly across the disease continuum, from population-level risk assessment and screening to mechanistic studies of early carcinogenesis and therapeutic innovation ... ...
